PMID- 34254320 OWN - NLM STAT- MEDLINE DCOM- 20211025 LR - 20220902 IS - 1600-065X (Electronic) IS - 0105-2896 (Print) IS - 0105-2896 (Linking) VI - 303 IP - 1 DP - 2021 Sep TI - Plasma cell biology: Foundations for targeted therapeutic development in transplantation. PG - 168-186 LID - 10.1111/imr.13011 [doi] AB - Solid organ transplantation is a life-saving procedure for patients with end-stage organ disease. Over the past 70 years, tremendous progress has been made in solid organ transplantation, particularly in T-cell-targeted immunosuppression and organ allocation systems. However, humoral alloimmune responses remain a major challenge to progress. Patients with preexisting antibodies to human leukocyte antigen (HLA) are at significant disadvantages in regard to receiving a well-matched organ, moreover, those who develop anti-HLA antibodies after transplantation face a significant foreshortening of renal allograft survival. Historical therapies to desensitize patients prior to transplantation or to treat posttransplant AMR have had limited effectiveness, likely because they do not significantly reduce antibody levels, as plasma cells, the source of antibody production, remain largely unaffected. Herein, we will discuss the significance of plasma cells in transplantation, aspects of their biology as potential therapeutic targets, clinical challenges in developing strategies to target plasma cells in transplantation, and lastly, novel approaches that have potential to advance the field. CI - (c) 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. FAU - Rossi, Amy P AU - Rossi AP AUID- ORCID: 0000-0003-0629-0603 AD - Division of Immunobiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA. AD - Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA. AD - Immunology Graduate Program, University of Cincinnati College of Medicine, Cincinnati, OH, USA. AD - Medical Scientist Training Program, University of Cincinnati College of Medicine, Cincinnati, OH, USA. FAU - Alloway, Rita R AU - Alloway RR AUID- ORCID: 0000-0003-4835-9197 AD - Division of Nephrology, Department of Internal Medicine, University of Cincinnati, Cincinnati, OH, USA. FAU - Hildeman, David AU - Hildeman D AUID- ORCID: 0000-0002-0421-8483 AD - Division of Immunobiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA. AD - Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA. AD - Immunology Graduate Program, University of Cincinnati College of Medicine, Cincinnati, OH, USA. FAU - Woodle, E Steve AU - Woodle ES AUID- ORCID: 0000-0003-4280-0842 AD - Division of Transplantation, Department of Surgery, University of Cincinnati College of Medicine, Cincinnati, OH, USA. LA - eng GR - R21 AI142264/AI/NIAID NIH HHS/United States GR - R01 AI154932/AI/NIAID NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't PT - Review DEP - 20210712 PL - England TA - Immunol Rev JT - Immunological reviews JID - 7702118 RN - 0 (HLA Antigens) RN - 0 (Isoantibodies) SB - IM MH - Graft Rejection MH - HLA Antigens MH - Humans MH - Isoantibodies MH - *Kidney Transplantation MH - Plasma Cells PMC - PMC8387355 MID - NIHMS1719312 OTO - NOTNLM OT - antibody-mediated rejection OT - desensitization OT - plasma cell OT - transplantation COIS- CONFLICT OF INTEREST There is no conflict of Interest to declare. EDAT- 2021/07/14 06:00 MHDA- 2021/10/26 06:00 PMCR- 2022/09/01 CRDT- 2021/07/13 06:41 PHST- 2021/06/08 00:00 [received] PHST- 2021/06/22 00:00 [accepted] PHST- 2021/07/14 06:00 [pubmed] PHST- 2021/10/26 06:00 [medline] PHST- 2021/07/13 06:41 [entrez] PHST- 2022/09/01 00:00 [pmc-release] AID - 10.1111/imr.13011 [doi] PST - ppublish SO - Immunol Rev. 2021 Sep;303(1):168-186. doi: 10.1111/imr.13011. Epub 2021 Jul 12.